RheSolve Study: Investigational device for the treatment of cough and phlegm

Trial ID:
IRB-21-7771
Samir Makani, MD
This study is being done to evaluate the safety and effectiveness of an investigational treatment for reducing the symptoms of chronic bronchitis, like cough and phlegm. The treatment is called Bronchial Rheoplasty and uses an investigational device called RheOx™.
•Be at least 35 years of age.<br>•Have chronic bronchitis, defined as productive cough for three months in each of two successive years, whereas other causes of productive cough have been excluded.<br>•Be able to walk over 225 meters in 6 minutes.<br>•Be receiving one or more long-acting bronchodilator medications (e.g. LAMA, LABA) with or without an inhaled corticosteroid for at least 8 weeks.<br>•Have a cigarette smoking history of at least ten pack years and must have abstained from active smoking for a minimum of 6 months.<br>•Meet all other eligibility criteria.<br>

Contact Info: